This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: location, two agreeing sources.

Myris Therapeutics

Myris Therapeutics reported $500,000 raised in an SEC Form D filed on 2026-10-14. State of the filing: Pennsylvania.

Industry
Biotechnology
Location
Pennsylvania

About

Myris Therapeutics appears in Section 3 of the Raise Track Update of 2026-10-15, which lists new SEC Form D filings. The filing reports $500,000 raised and gives Pennsylvania as the state. The industry on the filing is Biotechnology. Related persons named on the filing: Laura Benjamin (executive officer, director, Sharpsburg, Pennsylvania); Rebecca Wolfe (executive officer, Sharpsburg, Pennsylvania); Antonina Simakova (executive officer, Sharpsburg, Pennsylvania); Alan Russell (promoter, Sharpsburg, Pennsylvania); David Colaizzi (director, Sharpsburg, Pennsylvania); Barbara Fox (director, Sharpsburg, Pennsylvania); Krzysztof Matyjaszewski (director, Sharpsburg, Pennsylvania); Mark Murcko (director, Sharpsburg, Pennsylvania). Filing: https://www.sec.gov/Archives/edgar/data/1924725/000192472526000004/0001924725-26-000004-index.htm

This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.

Funding history

RoundDateAmountLead
Form D 20262026-10-14$500K

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/1924725/000192472526000004/0001924725-26-000004-index.htm
    Type: sec filing. Accessed 2026-10-15.
    SEC Form D for Myris Therapeutics, Inc. EDGAR filing date 2026-10-14. Signed 2026-10-14. First sale 2026-09-01. Total amount sold $500,000 of an offering amount of $4,500,000. 4 investors already invested. Issuer address city is Sharpsburg, Pennsylvania. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. The form includes middle initials on Laura E. Benjamin, David N. Colaizzi, Barbara S. Fox and Mark A. Murcko. The page uses Laura Benjamin, David Colaizzi, Barbara Fox and Mark Murcko.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
    Type: other verified public source. Accessed 2026-10-15.
    Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Myris Therapeutics, state PENNSYLVANIA, industry Biotechnology, amount raised $500,000.